National Vision Holdings

EYE · NASDAQ

$17.95+$0.43 (+2.45%)TodayMarket closed ·
Prev close $17.52

EYE analyst rating

BuyConsensus of 7 analysts over the last 12 months. 71% rate it a buy.
  • Strong buy0
  • Buy5
  • Hold2
  • Underperform0
  • Sell0

12-month price target · 12 analysts

Average $29.30 (+63.2% upside)

Low
$20.20
Now
$17.95
High
$36.75

Upgrades and downgrades

The latest rating actions, newest first

EYE analyst upgrades, downgrades and rating actions
FirmDateActionRating
UBSAug 13, 2026MaintainsBuy
CitigroupAug 13, 2026MaintainsBuy
Morgan StanleyAug 13, 2026MaintainsEqual-Weight
CitigroupMay 15, 2026MaintainsBuy
UBSMay 14, 2026MaintainsBuy
Morgan StanleyMay 14, 2026MaintainsEqual-Weight
Wells FargoMay 14, 2026MaintainsEqual-Weight
BarclaysMay 14, 2026MaintainsOverweight
B of A SecuritiesMay 14, 2026MaintainsBuy
CitigroupMar 5, 2026MaintainsBuy

The case for and against

Updated Nov 7, 2025

Bull case

National Vision Holdings Inc. has demonstrated a positive trajectory in its financial outlook, with expected earnings per share (EPS) increases for FY25 and FY26, rising to $0.65 and $0.76, respectively, an adjustment that reflects improved performance compared to previous estimates. The company's revenue potential could exceed estimates if store openings accelerate or if Net Sales Proceeds (NSP) improve, with projections indicating a possible EPS of approximately $1.70 driven by higher margins and productivity gains. Additionally, National Vision's recent first-quarter results were better than anticipated, leading to an upward revision in full-year guidance, which underscores a strong operational outlook for the company.

Bear case

National Vision Holdings, an optical retailer in the U.S., faces significant risks that could negatively impact its revenues and margins, particularly due to intensified competition from direct-to-consumer (DTC) brands and potential worsening of the National Store Performance (NSP). The company's projected earnings per share (EPS) of approximately $0.35, in conjunction with a structural margin outlook that anticipates only flat gross margin rates for fiscal 2025, raises concerns over profitability. Additional risks include legislative actions affecting optometry services, shifts in consumer preferences, and a heavy reliance on a limited number of suppliers, which could further exacerbate the company's challenges.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.